Post by David Grey on Nov 21, 2017 12:14:22 GMT -5
The primary objective of this study is to evaluate the potential for a pharmacokinetic (PK) drug-drug interaction between ubrogepant and sumatriptan in healthy adult participants.
50 West 84Th Street Miami, FL 33014-3616
(305) 817-8722
Sponsored By: Clinical Pharmacology of Miami Stipend: $1400 - $1400 Length of Study: 6 weeks Research Facility: In-Patient Gender: Both Age: 18 - 45 Health Condition: *Healthy Volunteers Studies
More Information: 3 confinement periods of 2 nights/3 days and 1 follow up visit over appmately 3 days.